Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALOR-HCM, demonstrating significant benefit in patients treated with CAMZYOS versus placebo

News | Pharmaceuticals

Bristol Myers Squibb Receives European Commission Approval of CAMZYOS (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)

June 28, 2023 — Bristol Myers Squibb announced that the European Commission (EC) has approved CAMZYOS (mavacamten, 2.5 ...

June 28, 2023

Global clinical study aims to broaden evidence base by assessing clinical and economic benefits for the FFRangio System

News | FFR Technologies

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

June 28, 2023 — CathWorks announced that the first patient has been enrolled in the Advancing Cath Lab Results with FFRa ...

June 28, 2023

This study aimed to evaluate the association between LDL-C levels, post-stroke infection and all-cause mortality. 804,855 ischemic stroke patients were enrolled.

News | Stroke

U-shaped Association Between Low-density Lipoprotein Cholesterol Levels and Risk of All-cause Mortality Mediated by Post-stroke Infection in Acute Ischemic Stroke

June 28, 2023 — The general perception supports the mantra of “lower is better” for low-density lipoprotein cholesterol ...

June 28, 2023

Ground-breaking new Perspectum research using Magnetic Resonance Imaging (MRI) AI-enabled assessment tools has revealed that patients with liver disease are at considerably higher risk of heart failure and other serious heart-related problems.

News | Magnetic Resonance Imaging (MRI)

New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

June 28, 2023

Day-long summit organized by CRF and Fogarty Innovation will convene clinicians, entrepreneurs, industry, and government stakeholders for education, collaboration, and real-world insight

News | Stents Carotid

InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial

June 26, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of str ...

June 26, 2023

Randomized clinical trial enrolled patients with acute chest pain, mildly elevated troponin

News | Cardiovascular Clinical Studies

Less-invasive Cardiac MRI Is a Valuable Diagnostic Tool in the Early Evaluation of Patients with Acute Chest Pain

June 22, 2023 — An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly ...

June 22, 2023

The Society of Interventional Radiology (SIR) published a new position statement offering recommendations on the management of chronic iliofemoral venous obstruction with endovascular placement of metallic stents.

News | Interventional Radiology

Newly Published Society of Interventional Radiology Position Statement Outlines Appropriate Use of Endovascular Management for Treatment of Chronic Iliofemoral Venous Occlusions

June 22, 2023 — The Society of Interventional Radiology (SIR) published a new position statement offering ...

June 22, 2023

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).

News | Peripheral Artery Disease (PAD)

Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

June 16, 2023

Out-of-hospital cardiac arrests (OCHA) cause significant mortality and morbidity, and the study is one the largest trials ever conducted on cardiac arrest patients admitted to intensive care units (ICU).

News | Cardiovascular Clinical Studies

New Data from Global TAME Study Supports Current Management of CO2 Levels in Cardiac Arrest Patients

June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found ...

June 16, 2023

News | Cardiovascular Clinical Studies

Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of bemp ...

June 16, 2023

Kandu Health is working to fulfill an urgent need in healthcare by supporting stroke patients beyond the hospital through a team of clinically licensed navigators, community support groups, and an easy-to-use app.

News | Cardiovascular Clinical Studies

Kandu Health Achieves Successful Enrollment of the First 50 Stroke Survivors in its Stroke Recovery Program, Appoints New Leadership

June 15, 2023 — Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and ...

June 15, 2023

NIH-supported study could lead to less restrictions for those with hypertrophic cardiomyopathy

News | Cardiovascular Clinical Studies

Vigorous Exercise Not Tied to Increased Risk of Adverse Events in Rare Heart Condition

June 14, 2023 — Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for ...

June 14, 2023

The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries

News | Stroke

Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program

June 14, 2023 — Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...

June 14, 2023

The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease

News | Stents

Gore Initiates Study to Compare the Gore Viabahn VBX Balloon Expandable Endoprosthesis to Bare Metal Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study (NCT05811 ...

June 13, 2023

In combination with BIOTRONIK Home Monitoring the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden

News | Remote Monitoring

REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients

June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset ...

June 13, 2023